Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 9041-93-4 | Product Number: B3972
Bleomycin Sulfate (mixture)
Purity: >85.0%(HPLC)
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
10MG |
$193.00
|
Contact Us | 2 | ≥100 |
|
50MG |
$594.00
|
3 | 1 | ≥100 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
Product Number | B3972 |
Purity / Analysis Method | >85.0%(HPLC) |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container | 10MG-Glass Bottle with Plastic Insert (View image), 50MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 9041-93-4 |
Related CAS RN | 11056-06-7 |
PubChem Substance ID | 253659941 |
Merck Index (14) | 1318 |
MDL Number | MFCD00070310 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min.85.0 area% (Sum of A2,B2) |
BleomycinA2 | 55.0 to 70.0 area% |
BleomycinB2 | 25.0 to 32.0 area% |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H351 : Suspected of causing cancer. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | EC5991990 |
HS Number | 2941.90.3000 |
Reference
- The Role of Drug Repurposing in the Development of Novel Antimicrobial Drugs: Non-Antibiotic Pharmacological Agents as Quorum Sensing-Inhibitors
References
- 1) Identification and validation of small molecules that enhance recombinant adeno-associated virus transduction following high-throughput screens
References
- Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice
- Regulation of type II alveolar epithelial cell proliferation by TGF-beta during bleomycin-induced lung injury in rats
- Production of superoxide and nitric oxide by alveolar macrophages in the bleomycin-induced interstitial pneumonia mice model
- Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation
- Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model
- In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats
- Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
References
- Modeling pulmonary fibrosis with bleomycin
- Pulmonary fibrosis: searching for model answers
References
- Mechanisms of bleomycin-induced DNA degradation (a review)
- Cleavage of Nucleic Acids by Bleomycin (a review)
- Bleomycin: New Perspectives on the Mechanism of Action (a review)
- Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin (a review)
- Direct Hydrogen-Atom Abstraction by Activated Bleomycin: An Experimental and Computational Study
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.